Literature DB >> 3036938

Vitamin E deficiency and its clinical significance in adults with primary biliary cirrhosis and other forms of chronic liver disease.

G P Jeffrey, D P Muller, A K Burroughs, S Matthews, C Kemp, O Epstein, T A Metcalfe, E Southam, M Tazir-Melboucy, P K Thomas.   

Abstract

The vitamin E status of 146 adults with chronic liver disease was assessed by estimating both their serum vitamin E concentration and the ratio of serum vitamin E to serum cholesterol concentration. Low levels of vitamin E occurred most frequently in patients with primary biliary cirrhosis and other forms of chronic cholestatic liver disease. When a serum vitamin E concentration of 12.3 mumol/l (mean-2 SD of a control population) was taken as the lower limit of normal, 44% of patients with primary biliary cirrhosis and 32% with other chronic cholestatic liver disease had a reduced concentration, indicating a biochemical deficiency of vitamin E. If a vitamin E/total cholesterol ratio of 2.35 mumol/mmol was taken as the lower limit of normal, then 64% and 43% of patients with primary biliary cirrhosis and other chronic cholestatic liver disease, respectively, had a biochemical deficiency of vitamin E. Of the patients with chronic cholestasis and a serum bilirubin concentration greater than 100 mumol/l, 91% had a reduced vitamin E/cholesterol ratio. Twelve patients with primary biliary cirrhosis and severe vitamin E deficiency (serum vitamin E less than 5.0 mumol/l and a vitamin E/cholesterol ratio less than 1.0 mumol/mmol) underwent extensive neurological investigation. Five had a mild mixed sensorimotor peripheral neuropathy, which was not, however, typical of the neurological syndrome associated with vitamin E deficiency. In patients with severe biochemical deficiency of vitamin E (less than 5 mumol/l and less than 1 mumol/mmol total cholesterol), administration of large oral doses of vitamin E only increased serum concentrations to within the normal range in one patient; in the others even weekly parenteral administration over a 3-month period did not correct deficiency. In patients with less severe biochemical deficiency, the serum vitamin E concentration and vitamin E/total cholesterol ratio were restored to normal by oral or intramuscular supplements of the vitamin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3036938     DOI: 10.1016/s0168-8278(87)80539-1

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  6 in total

1.  Vitamin E concentrations in human brain of patients with Alzheimer's disease, fetuses with Down's syndrome, centenarians, and controls.

Authors:  T Metcalfe; D M Bowen; D P Muller
Journal:  Neurochem Res       Date:  1989-12       Impact factor: 3.996

2.  Increased ethane exhalation, an in vivo index of lipid peroxidation, in alcohol-abusers.

Authors:  P Lettéron; V Duchatelle; A Berson; B Fromenty; C Fisch; C Degott; J P Benhamou; D Pessayre
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

3.  Resistance of erythrocytes to lipid peroxidation in alcoholic patients.

Authors:  N A Punchard; H Senturk; J P Teare; R P Thompson
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

Review 4.  Nutritional issues in patients with obesity and cirrhosis.

Authors:  Luigi Schiavo; Luca Busetto; Manuela Cesaretti; Shira Zelber-Sagi; Liat Deutsch; Antonio Iannelli
Journal:  World J Gastroenterol       Date:  2018-08-14       Impact factor: 5.742

Review 5.  The Role of Vitamin Deficiency in Liver Disease: To Supplement or Not Supplement?

Authors:  Anna Licata; Maddalena Zerbo; Silvia Como; Marcella Cammilleri; Maurizio Soresi; Giuseppe Montalto; Lydia Giannitrapani
Journal:  Nutrients       Date:  2021-11-10       Impact factor: 5.717

6.  Systemic mononuclear inflammatory vasculopathy associated with Sjögren's syndrome in a patient with primary biliary cirrhosis.

Authors:  J K Min; K S Park; W J Yu; Y S Lee; S M Park; S H Park; C S Cho; H Y Kim
Journal:  Korean J Intern Med       Date:  2000-01       Impact factor: 2.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.